Four insights:
1. The deal is part of Spectrum’s plan to develop its presence in the international medical device market.
2. Earnan develops custom balloon designs with materials such as nylon, polyurethane and polyester, which have multiple uses for wound care, neurovascular and orthopedic solutions among others.
3. This is Spectrum’s first acquisition after its Fermatex Vascular Technologies takeover in May 2018.
4. Terms of the agreement were not disclosed.
More articles on devices:
SEC ends investigation into Misonix over Chinese business partner
Zimmer Biomet replaces retiring CFO
Pacira appoints former Johnson & Johnson exec Max Reinhardt president
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.